Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome

Massimo Cugno, Miguel Dominguez, Mara Cabibbe, Giuliana Bisiani, Monica Galli, Edouard Angles-Cano, Angelo Agostoni

Research output: Contribution to journalArticlepeer-review


A reduction in fibrinolysis has been described in association with thrombosis in the primary antiphospholipid syndrome (PAPS). In this study, we measured anti-tissue-type plasminogen activator (t-PA) antibodies and anti- fibrin-bound t-PA antibodies as possible causes of hypofibrinolysis in 39 patients with PAPS. We also evaluated the differences in anti t-PA antibodies between patients without previous thrombosis (20 patients) and patients with previous episodes of thrombosis (19 patients: deep vein thrombosis in nine, ischaemic stroke in six, arterial leg thrombosis in ene, hepatic vein thrombosis in one, thrombophlebitis in one and cerebral venous thrombosis in one). Anti-t-PA antibodies were measured by an enzyme-linked immunosorbent assay (ELISA), and anti-t-PA fibrin-bound antibodies were measured by a solid-phase fibrin immunoassay (SOFIA) in 39 patients with PAPS and in 39 controls matched for gender and age. High levels of IgG anti-t-PA were found in three out of 39 patients with PAPS, and all three patients had a history of thrombosis; four other patients, one of whom had a history of thrombotic events, had high titres of antibodies directed against fibrin-bound t-PA. In addition, patients with ischaemic stroke had significantly higher level of IgG anti-t-PA than patients without thrombosis (P = 0.029). In conclusion, our data showed that, in patients with PAPS, the highest levels of anti-t-PA antibodies were present in subjects with previous thrombotic events. The discrepancy in the results obtained with two methods of detection of anti-t- PA antibodies. ELISA and SOFIA, indicates a different interaction of the antibodies with the t-PA molecules, which are directly bound to polystyrene plates in ELISA and bound to fibrin as a bridging molecule in SOFIA.

Original languageEnglish
Pages (from-to)871-875
Number of pages5
JournalBritish Journal of Haematology
Issue number4
Publication statusPublished - 2000


  • Antibodies
  • Hypofibrinolysis
  • Primary antiphospholipid syndrome
  • Thrombosis
  • Tissue-type plasminogen activator

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome'. Together they form a unique fingerprint.

Cite this